Tridek-One
Pre-clinicalTridek-One is a private biotechnology company founded in 2018, based on groundbreaking research by our scientific founders at INSERM.
Founded
2018
Focus
Small Molecules
About
Tridek-One is a private biotechnology company founded in 2018, based on groundbreaking research by our scientific founders at INSERM.
Funding History
2Total raised: $30M
Series A$25MSofinnova PartnersJul 15, 2022
Seed$5MSofinnova PartnersNov 15, 2020
Company Info
TypePrivate
Founded2018
LocationParis, France
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile